From biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer and more productive lives. We have been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations. Our team of over 80 distinguished scientific, medical, investment and other professionals manage approximately $11 billion across public and private company investments worldwide.
OrbiMed's flagship public equity strategy is a hedge fund launched in 1993 that invests both long and short in the global healthcare sector. This strategy employs a global event-driven, fundamental research approach that seeks to identify mispriced securities with a pending catalyst for value realization. Additionally, OrbiMed manages the Worldwide Healthcare Trust PLC, the Biotechnology Growth Trust PLC, and other public equity funds.OrbiMed's Asia private equity strategy is focused on opportunities in China and India across all sectors of healthcare, including healthcare services. Led by a dedicated team based in Shanghai and Mumbai, OrbiMed is able to combine the strengths of its local team with the resources of its global platform to assist companies in Asia with their growth objectives.